ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,635Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 559

$847K Total Retail Price of All Prescriptions

Rank: 4 out of 559

773 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
16% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 773 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

8% of this provider’s 773 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 10,805 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

16 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LEVOTHYROXINE SODIUM 720 655 1 2
SIMVASTATIN 710 655 2 3
LISINOPRIL 401 348 3 1
OMEPRAZOLE 363 314 4 4
METFORMIN HCL 334 278 5 5
LOVASTATIN 235 201 6 10
FUROSEMIDE 234 203 7 11
HYDROCODONE-ACETAMINOPHEN 217 178 S3 8 7
LOSARTAN POTASSIUM 214 201 9 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 201 160 10 18
METOPROLOL TARTRATE 188 179 11 12
AMLODIPINE BESYLATE 185 170 12 6
JANUVIA 180 160 13 50
FINASTERIDE 174 174 14 59
GABAPENTIN 167 125 15 9
OXYCODONE HCL 161 100 S2 16 32
FLUTICASONE PROPIONATE 160 122 17 22
CRESTOR 159 152 18 33
ATORVASTATIN CALCIUM 147 131 19 20
LOSARTAN-HYDROCHLOROTHIAZIDE 142 138 20 52
ADVAIR DISKUS 139 126 21 46
METOPROLOL SUCCINATE 137 120 22 16
SERTRALINE HCL 130 122 23 19
ALENDRONATE SODIUM 125 115 24 13
ATENOLOL 124 112 25 15
DOXAZOSIN MESYLATE 121 121 26 43
FLUOXETINE HCL 119 109 27 37
HYDROCHLOROTHIAZIDE 118 116 28 8
ZOLPIDEM TARTRATE 112 84 29 17
POTASSIUM CHLORIDE 104 95 30 23
OXYCODONE-ACETAMINOPHEN 103 80 S2 31 44
TRIAMTERENE-HCTZ 101 83 32 47
GLIPIZIDE 100 98 33 31
FELODIPINE ER 100 99 33 72
TAMSULOSIN HCL 99 96 35 25
DONEPEZIL HCL 98 98 36 36
CARVEDILOL 94 82 37 38
ALLOPURINOL 91 91 38 34
PRAVASTATIN SODIUM 88 81 39 35
RANITIDINE HCL 87 81 40 26
WARFARIN SODIUM 85 81 41 24
TRAMADOL HCL 85 72 41 27
DILTIAZEM 24HR ER 83 80 43 177
TRAZODONE HCL 78 72 44 28
MIRTAZAPINE 75 67 45 61
CITALOPRAM HBR 72 61 46 21
VENTOLIN HFA 70 59 47 113
ENDOCET 70 41 S2 47 105
PANTOPRAZOLE SODIUM 69 63 49 41
GLIMEPIRIDE 68 63 50 53
NAMENDA 68 68 50 56
ESTRADIOL 62 60 R 52 117
FENOFIBRATE 59 58 53 69
AZITHROMYCIN 58 50 54 39
ENALAPRIL MALEATE 58 56 54 66
DIGOXIN 57 57 56 94
VENLAFAXINE HCL ER 56 41 57 111
INSULIN SYRINGE 55 52 58 65
ACETAMINOPHEN-CODEINE 54 39 S3 59 83
CELEBREX 54 54 59 86
PREDNISONE 53 46 61 49
SYMBICORT 52 43 62 175
FENTANYL 51 45 S2 63 88
PAROXETINE HCL 50 39 64 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.